Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SMMT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
38 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
242 filers reported a long position in SMMT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | $477.7M | 32.8M | -9.9% |
| FMR LLC | $146.3M | 10M | -7.5% |
| STATE STREET CORP | $139M | 9.5M | +35.7% |
| BlackRock, Inc. | $138.8M | 9.5M | -1.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | $83.6M | 5.7M | +0.4% |
| UBS Group AG | $76.3M | 5.2M | +42.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $73.5M | 5M | -3.7% |
| GOLDMAN SACHS GROUP INC | $65.8M | 4.5M | +1,352.5% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $56.7M | 3.9M | -53% |
| Point72 Asset Management, L.P. | $53.9M | 3.7M | +371.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.